Han Hui Zhang
Chief Executive Officer at VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD.
Han Hui Zhang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD. | Director/Board Member | 2019-05-19 | - |
| Chief Executive Officer | 2019-05-19 | - | |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Director/Board Member | - | - |
Career history of Han Hui Zhang
Statistics
International
| China | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD. | Technology Services |
| Private companies | 1 |
|---|---|
Jilin Wanfang Baiao Biotechnology Co., Ltd.
Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Health Technology |
- Stock Market
- Insiders
- Han Hui Zhang
- Experience
